Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ZIMLAB.NSE
- Price
- 86.66
- Stock movement up
- +0.68 (0.79%)
- Company name
- Zim Laboratories Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 4.22B
- Ent value
- 6.02B
- Price/Sales
- 1.09
- Price/Book
- 1.74
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 26.15
- Forward P/E
- -
- PEG
- -
- EPS growth
- -17.83%
- 1 year return
- -13.30%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-15
DIVIDENDS
ZIMLAB.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 26.15 |
| Price to OCF | 53.65 |
| Price to FCF | 53.65 |
| Price to EBITDA | 33.39 |
| EV to EBITDA | 47.59 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.09 |
| Price to Book | 1.74 |
| EV to Sales | 1.55 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 48.73M |
| EPS (TTM) | 3.32 |
| FCF per share (TTM) | 1.62 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.88B |
| Gross profit (TTM) | 1.71B |
| Operating income (TTM) | 235.46M |
| Net income (TTM) | 161.50M |
| EPS (TTM) | 3.32 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 44.14% |
| Operating margin (TTM) | 6.07% |
| Profit margin (TTM) | 4.16% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 50.75M |
| Net receivables | 0.00 |
| Total current assets | 1.92B |
| Goodwill | 1.69M |
| Intangible assets | 280.96M |
| Property, plant and equipment | 0.00 |
| Total assets | 4.27B |
| Accounts payable | 477.23M |
| Short/Current long term debt | 1.01B |
| Total current liabilities | 1.31B |
| Total liabilities | 1.85B |
| Shareholder's equity | 2.43B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 78.71M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 78.71M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 6.65% |
| Return on Assets | 3.78% |
| Return on Invested Capital | 5.32% |
| Cash Return on Invested Capital | 2.59% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 88.80 |
| Daily high | 88.80 |
| Daily low | 85.10 |
| Daily Volume | 51K |
| All-time high | 149.00 |
| 1y analyst estimate | - |
| Beta | 0.57 |
| EPS (TTM) | 3.32 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| ZIMLAB.NSE | S&P500 | |
| Current price drop from All-time high | -41.84% | -12.89% |
| Highest price drop | -68.88% | -56.47% |
| Date of highest drop | 21 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -24.87% | -11.07% |
| Avg time to new high | 54 days | 12 days |
| Max time to new high | 422 days | 1805 days |
COMPANY DETAILS
Marketcap
4.22B
Marketcap category
Mid-cap
Description
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
Employees
556
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found